Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 6851 (MIR6851; hsa-mir-6851) is classified as a human microRNA, part of a large class of small non-coding RNAs that function mainly as post-transcriptional regulators of gene expression[3]. MicroRNAs play important roles across cellular differentiation, proliferation, apoptosis, development, and disease[2][3]. However, there is no credible published evidence linking MIR6851 to any specific biological function, molecular pathway, disease mechanism, or therapeutic modality. It is not recognized as a canonical therapeutic target and does not fall under typical protein-based therapeutic target families such as receptors, ion channels, transporters, or enzymes[2][3]. As of this writing, it primarily remains a locus with very limited characterization or functional annotation in the biomedical literature. The gene symbol and aliases are consistent with microRNA naming conventions, but MIR6851 has no known direct role as a target or biomarker. There is a lack of evidence for disease relevance, therapeutic targeting, or mechanistic action, differentiating it from well-studied microRNAs such as miR-155 or miR-146a, which have established roles in cancer, immunity, and other conditions[1][2]. This entry is likely included in public databases due to high-throughput sequencing efforts, but without functional follow-up or validation. The field of microRNA biology is broad and evolving, and future research might clarify its relevance, but as of now, MIR6851 should not be classified as a validated or established biomedical target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 6851 (MIR6851).